If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Further re Acquisition

9 Jan 2008 08:46

Mercury Group PLC09 January 2008 9 January 2008 Mercury Group Plc (the "Company") Further re: Acquisition of Smith Melzack Pepper Angliss Limited The Company announces that it has entered into a Settlement Agreement with thevendors of Smith Melzack Pepper Angliss Limited ("SMPA") ("the Vendors"), whichwas acquired by the Company on 28 February 2005. Under the terms of the original sale and purchase agreement, the Vendors wereentitled to receive, under certain circumstances, deferred consideration andfurther deferred consideration. In November 2006, the Company notified the Vendors of certain claims for breachof warranty relating to PAYE claims ("the PAYE Claim"). The Company and the Vendors have agreed that in settlement of the PAYE Claim andany other warranty claims whether now or in the future, certain of theentitlement of the Vendors to the deferred consideration and the furtherdeferred consideration shall be set-off against the PAYE Claim, and the finalamount of the deferred consideration and further deferred consideration is£182,000 to be satisfied as follows: (a) as to 50 per cent. of such sum by the issue and allotment to the Vendors of,in aggregate, 4,550,000 ordinary shares in the issued share capital of theCompany ("Deferred Consideration Shares"); and (b) as to the remaining 50 per cent. by the issue of £91,000 in nominal amountof convertible unsecured loan stock ("Loan Stock"). The Loan Stock is convertible into ordinary shares in the Company at any time upto the first anniversary of issue at the rate of 50 ordinary shares for every £1nominal of Loan Stock. If the Loan Stock is not converted by such time, it shallbe repaid on the first anniversary of issue, together with interest accrued. TheLoan Stock will carry interest of 1.5 per cent. over three month LIBOR payablequarterly in arrears. The number of Deferred Consideration Shares and the nominal amount of the LoanStock shall be increased in equal proportions if and to the extent that theamount paid by the Company in full and final settlement of the PAYE Claim isless than £110,560. Any further ordinary shares will be issued at a price of 2pper share and any Loan Stock will be issued at par. Ronnie Franks, Stuart Sandler, Clive Orman, Alan Kleinman, Paul Vernon-Smith andColin Povey, who are directors of the Company and/or SMPA, comprise the Vendors.Accordingly, the Settlement Agreement is classified as a related partytransaction under the AIM Rules. The independent directors consider, havingconsulted with John East & Partners Limited, that the terms of the transactionare fair and reasonable insofar as the shareholders of Mercury are concerned. Application will be made for 4,550,000 ordinary shares to be admitted to tradingon the AIM Market and dealings are expected to commence on 14 January 2008. Enquiries: Mercury Group Plc George Kynoch - Chairman 020 7343 4000 John East & Partners Limited David Worlidge 020 7628 2200 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Aug 20225:33 pmRNSHolding(s) in Company
1st Aug 20222:58 pmRNSIssue of Equity and Total Voting Rights
1st Aug 202212:13 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSTrading update and full year outlook
25th Jul 20222:30 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSBlock Listing Application
28th Jun 202212:46 pmRNSHolding(s) in Company
27th Jun 20221:58 pmRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
27th May 20225:22 pmRNSNotice of AGM
19th May 20227:00 amRNSHolding(s) in Company
12th Apr 202211:29 amRNSPublication of Annual Report
4th Apr 20227:00 amRNSResults for the year ended 31 December 2021
9th Mar 20224:40 pmRNSSecond Price Monitoring Extn
9th Mar 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20224:35 pmRNSPrice Monitoring Extension
16th Feb 202211:22 amRNSHolding(s) in Company
4th Feb 20223:05 pmRNSNotification of Major Holdings
28th Jan 20222:02 pmRNSNotification of Major Holdings
27th Jan 20221:19 pmRNSNotification of Major Shareholdings
26th Jan 20227:00 amRNSTrading and Business Update
24th Jan 20228:00 amRNSHolding(s) in Company
7th Jan 20227:00 amRNSAppointment of Numis as Joint Broker
5th Jan 20223:21 pmRNSBlock listing Interim Review
30th Dec 20213:48 pmRNSIssue of Equity
20th Dec 20214:36 pmRNSPrice Monitoring Extension
20th Dec 20218:00 amRNSHolding(s) in Company
25th Nov 20218:00 amRNSHolding(s) in Company
2nd Nov 202110:01 amRNSDirector/PDMR Shareholding
29th Oct 20219:18 amRNSTotal Voting Rights
8th Oct 20217:00 amRNSIssue of Equity
29th Sep 20217:00 amRNSRecord Date for Dividend – Correction
27th Sep 20217:00 amRNSInterim results for the six months to 30 June 2021
17th Sep 20211:47 pmRNSHolding(s) in Company
7th Sep 20217:00 amRNSCapital Markets Day
26th Aug 202110:17 amRNSHolding(s) in Company
17th Aug 202111:20 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSIssue of Equity and Total Voting Rights
22nd Jul 20217:00 amRNSTrading and business update
8th Jul 20219:28 amRNSHolding(s) in Company
5th Jul 202110:49 amRNSBlock Listing Application
22nd Jun 20211:45 pmRNSDirector/PDMR Shareholding
21st Jun 20217:00 amRNSDirector/PDMR Shareholding
16th Jun 20211:00 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
15th Jun 20217:40 amRNSDirector Declaration
15th Jun 20217:00 amRNSMedica appoints Barbara Moorhouse as NED
11th Jun 20214:34 pmRNSDirector/PDMR Shareholding
9th Jun 20219:05 amRNSHolding(s) in Company
4th Jun 20211:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.